117 related articles for article (PubMed ID: 12007541)
1. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.
Meier JJ; Gallwitz B; Schmidt WE; Nauck MA
Eur J Pharmacol; 2002 Apr; 440(2-3):269-79. PubMed ID: 12007541
[TBL] [Abstract][Full Text] [Related]
2. Effects of GLP-1 on appetite and weight.
Shah M; Vella A
Rev Endocr Metab Disord; 2014 Sep; 15(3):181-7. PubMed ID: 24811133
[TBL] [Abstract][Full Text] [Related]
3. Physiological functions of poorly absorbed polyphenols via the glucagon-like peptide-1.
Yamashita Y
Biosci Biotechnol Biochem; 2024 Apr; 88(5):493-498. PubMed ID: 38378922
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and crystallization of a novel glucagon analog as a therapeutic agent.
Li P; Rogers T; Smiley D; DiMarchi RD; Zhang F
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jul; 63(Pt 7):599-601. PubMed ID: 17620721
[TBL] [Abstract][Full Text] [Related]
5. Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions.
Astrup A
Eur J Clin Nutr; 2024 Jun; ():. PubMed ID: 38890501
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes: evidence from a retrospective real-world study.
Jiang Y; Bai HS; Liu GX; Wang SY; Yin L; Hou ZT; Zhao CY; Fan GJ
Front Endocrinol (Lausanne); 2024; 15():1347684. PubMed ID: 38524632
[TBL] [Abstract][Full Text] [Related]
7. Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism.
Huang Z; Liu L; Zhang J; Conde K; Phansalkar J; Li Z; Yao L; Xu Z; Wang W; Zhou J; Bi G; Wu F; Seeley RJ; Scott MM; Zhan C; Pang ZP; Liu J
Sci Adv; 2022 Jun; 8(23):eabn5345. PubMed ID: 35675406
[TBL] [Abstract][Full Text] [Related]
8. Transient Dexamethasone Loading Induces Prolonged Hyperglycemia in Male Mice With Histone Acetylation in Dpp-4 Promoter.
Uto A; Miyashita K; Endo S; Sato M; Ryuzaki M; Kinouchi K; Mitsuishi M; Meguro S; Itoh H
Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34480538
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic interaction between central glucagon-like Peptide-1 and oxytocin on diet-induced obesity mice.
Lee J; Moon H; Lee H; Oh Y; Kim C; Lee YH; Kim MS; NamKoong C; Lee HW; Kim JH; Choi HJ
Heliyon; 2020 Oct; 6(10):e05190. PubMed ID: 33088957
[TBL] [Abstract][Full Text] [Related]
10. Effects of Agave Fructans, Inulin, and Starch on Metabolic Syndrome Aspects in Healthy Wistar Rats.
Regalado-Rentería E; Aguirre-Rivera JR; Godínez-Hernández CI; García-López JC; Oros-Ovalle AC; Martínez-Gutiérrez F; Martinez-Martinez M; Ratering S; Schnell S; Ruíz-Cabrera MÁ; Juárez-Flores BI
ACS Omega; 2020 May; 5(19):10740-10749. PubMed ID: 32455193
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases.
Grieco M; Giorgi A; Gentile MC; d'Erme M; Morano S; Maras B; Filardi T
Front Neurosci; 2019; 13():1112. PubMed ID: 31680842
[TBL] [Abstract][Full Text] [Related]
12. Natural phenolic compounds potentiate hypoglycemia via inhibition of Dipeptidyl peptidase IV.
Huang PK; Lin SR; Chang CH; Tsai MJ; Lee DN; Weng CF
Sci Rep; 2019 Oct; 9(1):15585. PubMed ID: 31666589
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice.
Huang PK; Lin SX; Tsai MJ; Leong MK; Lin SR; Kankala RK; Lee CH; Weng CF
Nanomaterials (Basel); 2017 May; 7(5):. PubMed ID: 28498352
[TBL] [Abstract][Full Text] [Related]
14. Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides.
Sekar R; Wang L; Chow BK
Front Endocrinol (Lausanne); 2017; 8():18. PubMed ID: 28223965
[TBL] [Abstract][Full Text] [Related]
15. Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options.
Isidro ML; Cordido F
Pharmaceuticals (Basel); 2010 Jan; 3(1):125-145. PubMed ID: 27713245
[TBL] [Abstract][Full Text] [Related]
16. Long-term activation of PKA in β-cells provides sustained improvement to glucose control, insulin sensitivity and body weight.
Levine JA; Kaihara KA; Layden BT; Wicksteed B
Islets; 2016 Sep; 8(5):125-34. PubMed ID: 27340937
[TBL] [Abstract][Full Text] [Related]
17. Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome.
Ademoglu EN; Gorar S; Carlıoglu A; Yazıcı H; Dellal FD; Berberoglu Z; Akdeniz D; Uysal S; Karakurt F
J Endocrinol Invest; 2014 Aug; 37(8):715-719. PubMed ID: 24920281
[TBL] [Abstract][Full Text] [Related]
18. B-cell translocation gene 2 positively regulates GLP-1-stimulated insulin secretion via induction of PDX-1 in pancreatic β-cells.
Hwang SL; Kwon O; Kim SG; Lee IK; Kim YD
Exp Mol Med; 2013 May; 45(5):e25. PubMed ID: 23703573
[TBL] [Abstract][Full Text] [Related]
19. An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes.
Puddu A; Mach F; Nencioni A; Viviani GL; Montecucco F
Mediators Inflamm; 2013; 2013():591056. PubMed ID: 23365488
[TBL] [Abstract][Full Text] [Related]
20. The anorectic effect of GLP-1 in rats is nutrient dependent.
Sandoval D; Barrera JG; Stefater MA; Sisley S; Woods SC; D'Alessio DD; Seeley RJ
PLoS One; 2012; 7(12):e51870. PubMed ID: 23284795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
